Literature DB >> 11266237

Living with severe COPD. A qualitative exploration of the experience of patients in Leeds.

S J Guthrie1, K M Hill, M E Muers.   

Abstract

A sample of 37 patients with severe chronic obstructive pulmonary disease (COPD) drawn from a larger group of 64 patients being studied in a randomized trial of nebulizer versus high-dose inhaler therapy, and similar in age and gender mix, was interviewed in depth, with a view to illuminating standardized outcome measures and improving the understanding of these patients' needs. Three patients are described in detail. The interview material was analysed using non-computerized methods. Quality of life was seen as depending mainly on family relationships, opportunities afforded locally for neighbourliness and freedom from fear, mobility and independence in the activities of daily living, and the absence or successful mitigation of symptoms of concomitant disease. Disease-specific, symptom-oriented outcome measures may miss these. Additionally, the near and repeatedly threatening approach of death recommended extension of a palliative approach to endstage COPD.

Entities:  

Mesh:

Year:  2001        PMID: 11266237     DOI: 10.1053/rmed.2000.1021

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  23 in total

1.  New research initiatives in Canada for end-of-life and palliative care.

Authors:  Graeme Rocker; Daren Heyland
Journal:  CMAJ       Date:  2003-08-19       Impact factor: 8.262

Review 2.  Experiences of living and dying with COPD: a systematic review and synthesis of the qualitative empirical literature.

Authors:  M Giacomini; D DeJean; D Simeonov; A Smith
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

3.  Exploring self-conscious emotions in individuals with chronic obstructive pulmonary disease.

Authors:  Samantha L Harrison; Noelle Robertson; Roger S Goldstein; Dina Brooks
Journal:  Chron Respir Dis       Date:  2016-01-01       Impact factor: 2.444

4.  Patients' perspective of the impact of COPD on quality of life: a focus group study for patients with COPD.

Authors:  Anan Jarab; Eman Alefishat; Tareq Mukattash; Karem Alzoubi; Sharrel Pinto
Journal:  Int J Clin Pharm       Date:  2018-03-14

5.  Transitions regarding palliative and end-of-life care in severe chronic obstructive pulmonary disease or advanced cancer: themes identified by patients, families, and clinicians.

Authors:  Lynn F Reinke; Ruth A Engelberg; Sarah E Shannon; Marjorie D Wenrich; Elizabeth K Vig; Anthony L Back; J Randall Curtis
Journal:  J Palliat Med       Date:  2008-05       Impact factor: 2.947

6.  A day at a time: caregiving on the edge in advanced COPD.

Authors:  A Catherine Simpson; Joanne Young; Margaret Donahue; Graeme Rocker
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-06-03

7.  'Belonging'. 'Patients' experiences of social relationships during pulmonary rehabilitation.

Authors:  Anne-Grethe Halding; Astrid Wahl; Kristin Heggdal
Journal:  Disabil Rehabil       Date:  2010       Impact factor: 3.033

8.  Implementing a palliative care trial in advanced COPD: a feasibility assessment (the COPD IMPACT study).

Authors:  Robert Horton; Graeme Rocker; Andrea Dale; Joanne Young; Paul Hernandez; Tasnim Sinuff
Journal:  J Palliat Med       Date:  2013-01       Impact factor: 2.947

9.  End-of-life care for persons with advanced chronic obstructive pulmonary disease: report of a national interdisciplinary consensus meeting.

Authors:  D M Goodridge; D D Marciniuk; D Brooks; A van Dam; S Hutchinson; P Bailey; S Baxter; P Dorasamy; S Dumont; S Hassan; P Hernandez; A Kerigan; G Rocker; D Wilson; J Young
Journal:  Can Respir J       Date:  2009 Sep-Oct       Impact factor: 2.409

10.  The feasibility of a single-blinded fast-track pragmatic randomised controlled trial of a complex intervention for breathlessness in advanced disease.

Authors:  Morag C Farquhar; Irene J Higginson; Petrea Fagan; Sara Booth
Journal:  BMC Palliat Care       Date:  2009-07-07       Impact factor: 3.234

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.